Biocept to participate in the h.c. wainwright global investment conference

San diego--(business wire)--biocept, inc. (nasdaq: bioc) (“biocept” or the “company”), a leading provider of molecular diagnostic assays, products and services, announces that management will participate in the h.c. wainwright 25th annual global investment conference being held september 11-13, 2023. a webcast of the biocept presentation will be available on the events & presentation section of the company's website beginning monday, september 11 at 7:00 a.m. eastern time. management is ava.
BIOC Ratings Summary
BIOC Quant Ranking